ALLR

SEC source: 0001213900-26-108573 · ownership.xml · derivative · entry 6

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 269,122

Underlying: Common Stock · 39,494 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date.

F2 · derivative.expiration_date: On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date.

F4 · balance_after: The amount reported in column 9 reflects 175,283 restricted stock units outstanding following the January 22, 2026 settlement, plus 133,333 restricted stock units granted on January 28, 2026 and previously reported, less 39,494 restricted stock units settled on September 30, 2026.

SEC source: 0001213900-26-108573 · ownership.xml · nonDerivative · entry 4

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,095

F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations arising upon the vesting and settlement of restricted stock units. The shares were withheld based on the fair market value of the Issuer's common stock on the applicable vesting date.

F5 · balance_after: The 381,644 amount previously reported in column 5 of Table I of the Reporting Person's Form 4/A filed April 30, 2026 combined issued shares of common stock and unvested restricted stock units and did not reflect the 17,814 shares withheld on January 22, 2026. This Form 4 reports issued shares of common stock in Table I and unvested restricted stock units separately in Table II. After giving effect to the January 22, 2026 vesting and withholding and the January 28, 2026 restricted stock unit grant, the correct balances were 55,214 shares of common stock and 308,616 restricted stock units.

SEC source: 0001213900-26-108573 · ownership.xml · nonDerivative · entry 3

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001213900-26-050133 · ownership.xml · nonDerivative · entry 1

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,644

F1 · shares: The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date.

SEC source: 0001213900-26-050131 · ownership.xml · nonDerivative · entry 1

Ervin Jeffrey S · CIK 0001762163 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

F1 · shares: The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date.

SEC source: 0001213900-26-053466 · ownership.xml · nonDerivative · entry 1

McLaughlin Gerald W. · CIK 0001495412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

F1 · shares: The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, vested in full on the grant date.

SEC source: 0001213900-26-056373 · ownership.xml · nonDerivative · entry 1

Jensen Thomas · CIK 0001888277 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 596,734

F1 · shares: The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date.

SEC source: 0001213900-26-108573 · ownership.xml · derivative · entry 5

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,283

Underlying: Common Stock · 48,147 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date.

F2 · derivative.expiration_date: On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date.

SEC source: 0001213900-26-108573 · ownership.xml · nonDerivative · entry 2

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,214

F3 · shares: Represents shares withheld by the Issuer to satisfy tax withholding obligations arising upon the vesting and settlement of restricted stock units. The shares were withheld based on the fair market value of the Issuer's common stock on the applicable vesting date.

SEC source: 0001213900-26-108573 · ownership.xml · nonDerivative · entry 1

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,028

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001213900-26-005146 · ownership.xml · nonDerivative · entry 1

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,644

F1 · shares: The restricted stock units, or RSUs, granted on January 7, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date.

SEC source: 0001213900-26-054430 · ownership.xml · nonDerivative · entry 1

Hoeiland Jesper · CIK 0001711694 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

F1 · shares: The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, vested in full on the grant date.

SEC source: 0001213900-25-095391 · ownership.xml · derivative · entry 3

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,430

Underlying: Common Stock · 39,494 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date.

F2 · derivative.expiration_date: On September 30, 2024 and January 22, 2025, the Reporting Person was granted 118,483 and 144,441 restricted stock units, respectively, which vest in three equal annual installments beginning on the first anniversary of the applicable grant date.

SEC source: 0001213900-25-095391 · ownership.xml · nonDerivative · entry 2

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,881

SEC source: 0001213900-25-095391 · ownership.xml · nonDerivative · entry 1

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001437749-25-001806 · rdgdoc.xml · nonDerivative · entry 1

Epshinsky Alexander · CIK 0002037994 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,051

F1 · shares: The restricted stock units, or RSUs, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date.

SEC source: 0001437749-25-001854 · rdgdoc.xml · derivative · entry 1

Vazzano Joseph Walter · CIK 0001715291 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2035-01-22

F1 · derivative.exercise_date: The stock options, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc.'s Amended and Restated 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the anniversary of the grant and are exercisable beginning as of that date.

SEC source: 0001437749-25-001852 · rdgdoc.xml · derivative · entry 1

Benjamin Laura · CIK 0001990896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2035-01-22

F1 · derivative.exercise_date: The stock options, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc.'s Amended and Restated 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the anniversary of the grant and are exercisable beginning as of that date.

SEC source: 0001437749-25-001850 · rdgdoc.xml · derivative · entry 1

McLaughlin Gerald W. · CIK 0001495412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2035-01-22

F1 · derivative.exercise_date: The stock options, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc.'s Amended and Restated 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the anniversay of the grant and are exercisable beginning as of that date.

SEC source: 0001437749-25-001808 · rdgdoc.xml · nonDerivative · entry 1

Graff Jeremy R. · CIK 0001975028 · CDO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,924

F1 · shares: The restricted stock units, or RSUs, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date.

SEC source: 0001437749-25-001801 · rdgdoc.xml · nonDerivative · entry 1

Jensen Thomas · CIK 0001888277 · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 396,734

F1 · shares: The restricted stock units, or RSUs, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date.

SEC source: 0001437749-25-001798 · rdgdoc.xml · derivative · entry 1

McLaughlin Gerald W. · CIK 0001495412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2030-01-22

F1 · derivative.exercise_date: The stock options, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc.'s Amended and Restated 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

SEC source: 0001437749-25-001796 · rdgdoc.xml · derivative · entry 1

Vazzano Joseph Walter · CIK 0001715291 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2030-01-22

F1 · derivative.exercise_date: The stock options, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc.'s Amended and Restated 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

SEC source: 0001437749-25-001793 · rdgdoc.xml · derivative · entry 1

Benjamin Laura · CIK 0001990896 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2030-01-22

F1 · derivative.exercise_date: The stock options, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc.'s Amended and Restated 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.

SEC source: 0001213900-24-084163 · ownership.xml · nonDerivative · entry 1

Graff Jeremy R. · CIK 0001975028 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,483

F1 · shares: The Reporting Person was granted 118,483 restricted stock units, or RSUs, in connection with the Reporting Person's appointment as President and Chief Development Officer of the Issuer. The RSUs will vest in equal one-third installments on the first, second, and third anniversary of the Reporting Person's appointment, subject to the Reporting Person's continued relationship with the Issuer through each such date.